Trigevolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L2D8DE8S32. European Medicines Agency schedules Trigevolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11294MIG. Trigevolol generally arises in the molecular formula C21H28N2O7. The term TRIGEVOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, no. 4, 1987, list 27.) TRIGEVOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trigevolol under HS 29242995 and SITC 51479. As of Q4 2014, TRIGEVOLOL remains the US FDA Preferred Term for this commodity. Trigevolol bears US NLM identifiers UMLS ID C2825714 and NCI Concept Code C81657. SMILES: O(CC(O)CNCCOC1CC(C(O)CC1)C(=O)N)C1CCC(OCCOC)CC1.